Brief: Accuray Says Cyberknife Robotic Radiotherapy Platform Is Superior To Conventional Linear Accelerators
14/09/2021 12:36
Sept 14 (Reuters) - Accuray Inc ARAY.O :
* ACCURAY - CYBERKNIFE ROBOTIC RADIOTHERAPY PLATFORM IS
SUPERIOR
TO CONVENTIONAL LINEAR ACCELERATORS IN REDUCING INCIDENCE OF
BLADDER SIDE EFFECTS IN PROSTATE CANCER PATIENTS
* ACCURAY INC - PROSPECTIVE, RANDOMIZED, INTERNATIONAL
MULTICENTER
STUDY - PROSTATE ADVANCES IN COMPARATIVE EVIDENCE RESULTS
PRESENTED AT ESTRO 2021
Source text for Eikon: ID:nPn3L9MWQa
Further company coverage: ARAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Accuray Incorporated
See all newsBrief: Accuray And Raysearch Agree To Collaboration Integrating Raystation Software
Accuray Q4 revenue falls as tariff concerns, geopolitical tensions weigh on demand
Accuray Incorporated reports results for the quarter ended June 30 - Earnings Summary
Accuray Incorporated expected to post a loss of 10 cents a share - Earnings Preview
Brief: Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments